| Archive | |
| |
| 12 February 2007, Volume 96, Number 3 | |
| |
 | |
| Reviews | back to top |
| |
HIF and fumarate hydratase in renal cancer S Sudarshan, W M Linehan & L Neckers | |
| Abstract | Full Article | PDF |
403 |
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck C W M Reuter, M A Morgan & A Eckardt | |
| Abstract | Full Article | PDF |
408 |
| |
| Clinical Studies | back to top |
| |
EpCAM (CD326) finding its role in cancer P A Baeuerle & O Gires | |
| Abstract | Full Article | PDF |
417 |
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - a study of the United Kingdom Children's Cancer Study Group G J Veal, M Cole, J Errington, A D J Pearson, A B M Foot, G Whyman & A V Boddy on behalf of the UKCCSG Pharmacology Working Group | |
| Abstract | Full Article | PDF |
424 |
Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer V Chiarion-Sileni, L Corti, A Ruol, R Innocente, C Boso, P Del Bianco, J Pigozzo, R Mazzarotto, O Tomassi & E Ancona | |
| Abstract | Full Article | PDF |
432 |
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study E Bajetta, M Di Bartolomeo, R Buzzoni, L Mariani, N Zilembo, E Ferrario, S Lo Vullo, E Aitini, L Isa, C Barone, S Jacobelli, E Recaldin, G Pinotti & A Iop on behalf of the ITMO group | |
| Abstract | Full Article | PDF |
439 |
| |
| Translational Therapeutics | back to top |
| |
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels K S M Smalley, R Contractor, N K Haass, J T Lee, K L Nathanson, C A Medina, K T Flaherty & M Herlyn | |
| Abstract | Full Article | PDF |
445 |
Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells A M E Bruynzeel, M A Abou El Hassan, E Torun, A Bast, W J F van der Vijgh & F A E Kruyt | |
| Abstract | Full Article | PDF |
450 |
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells Y Nakano, S Tanno, K Koizumi, T Nishikawa, K Nakamura, M Minoguchi, T Izawa, Y Mizukami, T Okumura & Y Kohgo | |
| Abstract | Full Article | PDF |
457 |
Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells A M Grabowska, J Hughes & S A Watson | |
| Abstract | Full Article | PDF |
464 |
| |
| Molecular Diagnostics | back to top |
| |
Interleukin-6 gene amplification and shortened survival in glioblastoma patients A Tchirkov, T Khalil, E Chautard, K Mokhtari, L Véronèse, B Irthum, P Vago, J-L Kémény & P Verrelle | |
| Abstract | Full Article | PDF |
474 |
Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters J-P Yun, J Miao, G G Chen, Q-H Tian, C-Q Zhang, J Xiang, J Fu & P B S Lai | |
| Abstract | Full Article | PDF |
477 |
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway D Pils, A Pinter, J Reibenwein, A Alfanz, P Horak, B C Schmid, L Hefler, R Horvat, A Reinthaller, R Zeillinger & M Krainer | |
| Abstract | Full Article | PDF |
485 |
Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus K Kaneko, A Katagiri, K Konishi, T Kurahashi, H Ito, Y Kumekawa, T Yamamoto, T Muramoto, Y Kubota, H Nozawa, R Makino, M Kushima & M Imawari | |
| Abstract | Full Article | PDF |
492 |
Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array N Tørring, M Borre, K D Sørensen, C L Andersen, C Wiuf & T F Ørntoft | |
| Abstract | Full Article | PDF | Supplementary Information |
499 |
| |
| Epidemiology | back to top |
| |
Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis R J Stevens, A W Roddam & V Beral | |
| Abstract | Full Article | PDF |
507 |
Magnesium intake and colorectal cancer risk in the Netherlands Cohort Study P A van den Brandt, K M Smits, R A Goldbohm & M P Weijenberg | |
| Abstract | Full Article | PDF | Supplementary Information |
510 |
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland K M French, R V Barnabas, M Lehtinen, O Kontula, E Pukkala, J Dillner & G P Garnett | |
| Abstract | Full Article | PDF |
514 |
Temporal trends in non-small cell lung cancer survival in Sweden D R Brooks, Å Klint, P W Dickman, E St  hle & M Lambe | |
| Abstract | Full Article | PDF |
519 |
A comparison of sunlight exposure in men with prostate cancer and basal cell carcinoma N J Rukin, M P Zeegers, S Ramachandran, C J Luscombe, S Liu, M Saxby, J Lear & R C Strange | |
| Abstract | Full Article | PDF |
523 |
Mortality and incidence of second cancers following treatment for testicular cancer D Robinson, H Møller & A Horwich | |
| Abstract | Full Article | PDF |
529 |
| |
| Corrigendum | back to top |
| |
Ovarian cancer in younger vs older women: a population-based analysis J K Chan, R Urban, M K Cheung, K Osann, A Husain, N N Teng, D S Kapp, J S Berek, G S Leiserowitz & J Y Shin | |
| Abstract | Full Article | PDF |
534 |
| In this issue | |
| ||
 | Reviews | |
| Clinical Studies | |
| Translational Therapeutics | |
| Molecular Diagnostics | |
| Epidemiology | |
| Corrigendum | |
| ||
| ||
| ||
 | Preceding issue | |
 | Next issue | |
| ||
| ||
| ||
|
| ||
| ||
 | ||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2007 Cancer Research UK | ||
| |||
| Privacy Policy | |||